Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Fluvoxamine, sold under the brand name Luvox among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is primarily used to treat major depressive disorder and, perhaps more especially, obsessive–compulsive disorder (OCD), but is also used to treat anxiety disorders such as panic disorder, social anxiety disorder…
The analysis highlights History, Applications, Research and Standards as prominent areas in the source structure around Fluvoxamine.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Fluvoxamine shows recurring relationship patterns in the source. For example, Fluvoxamine → Abbott, Abbott Laboratories, At, BayPharma, Belgium, Drug Administration, FDA, Floxyfral, Food, In India, In Japan, It, Kali-Duphar, Luvox, Manufacturers, OCD, Solvay Pharmaceuticals, SSRI, Switzerland, Synthon Another extracted example is Fluvoxamine → Australia, In, In Japan, OCD, Of, Russia, SSRIs, The NICE, There, United Kingdom, United States. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
may ssris effects ssri serotonin anxiety also treatment sexual drug etc dysfunction reuptake ocd risk cyp2d6 cyp1a2 mg disorder social
TTTA extracted 119 structured relationships around Fluvoxamine. Examples in this analysis include Fluvoxamine → 3D model (JSmol) → Interactive image and Fluvoxamine → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Fluvoxamine | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Fluvoxamine | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Fluvoxamine | ATC code | N06AB08 (WHO) | 1.00 | infobox |
| Fluvoxamine | Bioavailability | 53% (90% confidence interval: 44–62%) | 1.00 | infobox |
| Fluvoxamine | CAS Number | 54739-18-3 Y | 1.00 | infobox |
| Fluvoxamine | ChEBI | CHEBI:5138 Y | 1.00 | infobox |
| Fluvoxamine | ChEMBL | ChEMBL814 Y | 1.00 | infobox |
| Fluvoxamine | ChemSpider | 4481878 Y | 1.00 | infobox |
| Fluvoxamine | CompTox Dashboard (EPA) | DTXSID2044002 | 1.00 | infobox |
| Fluvoxamine | Drug class | Selective serotonin reuptake inhibitor (SSRI) | 1.00 | infobox |
| Fluvoxamine | DrugBank | DB00176 N | 1.00 | infobox |
| Fluvoxamine | ECHA InfoCard | 100.125.476 | 1.00 | infobox |
| Fluvoxamine | Elimination half-life | 12–13 hours (single dose), 22 hours (repeated dosing) | 1.00 | infobox |
| Fluvoxamine | Excretion | Kidney (98%; 94% as metabolites, 4% as unchanged drug) | 1.00 | infobox |
| Fluvoxamine | Formula | C15H21F3N2O2 | 1.00 | infobox |
| Fluvoxamine | IUPHAR/BPS | 7189 | 1.00 | infobox |
| Fluvoxamine | KEGG | D07984 Y | 1.00 | infobox |
| Fluvoxamine | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Fluvoxamine | Legal status | BR: Class C1 (Other controlled substances) | 1.00 | infobox |
| Fluvoxamine | Legal status | CA: ℞-only | 1.00 | infobox |
| Fluvoxamine | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Fluvoxamine | Legal status | US: ℞-only | 1.00 | infobox |
| Fluvoxamine | License data | US DailyMed: Fluvoxamine | 1.00 | infobox |
| Fluvoxamine | MedlinePlus | a695004 | 1.00 | infobox |
| Fluvoxamine | Metabolism | Liver (primarily O-demethylation) Major: CYP2D6 or CYP1A2 Minor: CYP3A4, CYP2C19, and/or CYP1A2 | 1.00 | infobox |
| Fluvoxamine | Molar mass | 318.340 g·mol−1 | 1.00 | infobox |
| Fluvoxamine | Pregnancy category | AU: C | 1.00 | infobox |
| Fluvoxamine | Pronunciation | floo-VAHK-sə-meen UK: /fluːˈvɒksəmiːn/ US: /fluːˈvɑːksəˌmiːn/ | 1.00 | infobox |
| Fluvoxamine | Protein binding | 77–80% | 1.00 | infobox |
| Fluvoxamine | PubChem CID | 5324346 | 1.00 | infobox |
The concept neighborhoods around Fluvoxamine bring nearby vocabulary together. In this analysis, examples include May, Increase and Ssri. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Fluvoxamine, one of the stronger structural bridges in this analysis connects Fluvoxamine with Interactions. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Fluvoxamine to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Applications, Research & Standards, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Fluvoxamine · EN edition · Analysis: TopicsToTalkAbout